Warning letter
Vita Pure Inc [ARCHIVED]: warning letter of Feb 9, 2011
FDA warning letter 146153 · New Jersey District Office
Key facts
| Reference number | 146153 |
|---|---|
| Company | Vita Pure Inc [ARCHIVED] |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Feb 9, 2011 |
| Posted date | Feb 9, 2011 |
| Issuing office | New Jersey District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.73, 111.453, 111.35(b)(2), 111.35(b)(3), 111.205(a), 111.210(b), 111.210(c), 111.210(f), 111.210(h)(5), 111.255(b), 111.260(b) and 4 more |
| Inspection city | Roselle |
| Inspection ZIP | 07203 |
| Inspection start date | Sep 10, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: